| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 10/31/2001 | EP1149083A1 Morpholinobenzamide salts |
| 10/31/2001 | EP1149074A1 Acetylenic sulfonamide thiol tace inhibitors |
| 10/31/2001 | EP1148872A1 Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor |
| 10/31/2001 | CN1319431A Method for improving antitumor activity of amarogentin substance and its composition and evaluation method |
| 10/30/2001 | CA2165265C High hydroxyacid water in oil emulsion cosmetic or dermatologic composition |
| 10/25/2001 | WO2001078506A1 Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
| 10/25/2001 | WO2001027113A3 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
| 10/25/2001 | US20010034447 N-(5-tert-butyl-2-methoxyphenyl)-n'-(4-(1-oxoisoindolin-5-ylox y)penyl)urea as anticarcinogenic agents |
| 10/25/2001 | US20010034351 A quinazoline compound |
| 10/25/2001 | US20010034337 Antiproliferative agents |
| 10/25/2001 | US20010033865 Melt-extrusion multiparticulates |
| 10/24/2001 | EP1147212A1 T helper cell epitopes |
| 10/24/2001 | EP1147114A1 Novel aralkyl amines of spirofuropyridines useful in therapy |
| 10/24/2001 | EP1147093A1 Substituted bicyclic derivatives useful as anticancer agents |
| 10/24/2001 | EP1146886A1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 10/24/2001 | CN1319021A Chemokine receptor antagonist and ocyclosporin in combined therapy |
| 10/24/2001 | CN1319006A Use of organophosphorous compounds for producing medicaments for therapeutic and prophylactic treatment of infections or as fungicide, bactericide or herbicide for plants |
| 10/23/2001 | US6306398 Delipidating plant powder by extraction of powder with a solution containing organic solvent; separating powder from organic solvent; extracting delipidated powder with solvent or phosphate buffered saline; separation to obtain retentate |
| 10/23/2001 | CA2217227C Use of a partial or complete extract of not fermented camellia sinensis l. for the preparation of a medicament, a medical care product, a cosmetic preparation or a food complementary product |
| 10/23/2001 | CA2096346C Combinations of anthelmintically active agents |
| 10/18/2001 | WO2001077105A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 10/18/2001 | WO2001076558A1 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 10/18/2001 | WO2001076531A2 Bile acid containing prodrugs with enhanced bioavailability |
| 10/18/2001 | US20010031895 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines |
| 10/18/2001 | US20010031767 Used as antidepressants, to treat obsessive compulsive disorder, panic disorders, bulimia, anorexia, pain, obesity, senile demential, migraines, and social phobias |
| 10/18/2001 | US20010031246 Oral composition |
| 10/18/2001 | US20010029636 Peroxygen compound, buffering agent, cholesterol and/or derivatives thereof or mixtures thereof, characterised in that pH is greater than pH 10; prevention of damage to hair |
| 10/18/2001 | CA2405151A1 Bile acid containing prodrugs with enhanced bioavailability |
| 10/17/2001 | EP1144675A2 Pharmacokinetic-based drug design tool and method |
| 10/17/2001 | EP1144396A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 10/17/2001 | EP1144013A1 Lactone bearing absorbable polymers |
| 10/17/2001 | EP1143966A1 Preparation for warts |
| 10/17/2001 | EP1143961A2 Regulators of the ptc or smoothened pathway, compositions and uses related thereto |
| 10/17/2001 | EP1143956A2 Compositions and methods for the treatment of anorectal disorders |
| 10/17/2001 | EP1143940A2 Compositions and methods for mucosal delivery |
| 10/17/2001 | EP0999841B1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 10/17/2001 | EP0769965B1 Aqueous risperidone formulations |
| 10/17/2001 | CN1318067A Compounds, compsns. and methods for stimulating neuronal growth and elongation |
| 10/17/2001 | CN1318059A Isoquinolines as urokinase inhibitors |
| 10/17/2001 | CN1318057A 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoliines as CETP inhibitors |
| 10/17/2001 | CN1317977A Dry powder active agent pulmonary delivery |
| 10/17/2001 | CN1317960A Pharmaceutical compsn. comprising D-i(chiro)-inositol for improving insulin sensitivity and glucose metabolism |
| 10/16/2001 | US6303614 Tetrahydro gamma-carbolines |
| 10/16/2001 | US6303146 Solid oral dosage form comprising a combination of metformin and glibenclamide |
| 10/16/2001 | US6303125 Anti-microbial-adhesion fraction derived from vaccinium |
| 10/16/2001 | US6303103 1,1,1,2-tetrafluoroethane as propellant; inhalants. |
| 10/11/2001 | WO2001074820A1 Novel derivatives and analogues of galanthamin |
| 10/11/2001 | WO2001074775A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 10/11/2001 | WO2001074394A1 New combination of a betablocker and a cholesterol-lowering agent |
| 10/11/2001 | WO2001074369A1 Divided dose therapies with vascular damaging activity |
| 10/11/2001 | WO2001074368A1 Combination therapies with vascular damaging activity |
| 10/11/2001 | WO2001074341A2 Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant |
| 10/11/2001 | WO2000048606A9 Compositions and methods for use in targeting vascular destruction |
| 10/11/2001 | CA2404592A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 10/11/2001 | CA2403160A1 New combination of a betablocker and a cholesterol-lowering agent |
| 10/11/2001 | CA2402539A1 Combination therapies with vascular damaging activity |
| 10/11/2001 | CA2402078A1 Divided dose therapies with vascular damaging activity |
| 10/11/2001 | CA2368966A1 New derivatives and analogues of galanthamine |
| 10/10/2001 | EP1142930A1 Novel benzylidene malonate siloxane |
| 10/10/2001 | EP1142578A1 Method for producing an antitumoral agent and antitumoral agent thus obtained |
| 10/10/2001 | EP1141308A2 Group b streptococcus proteins, and their use |
| 10/10/2001 | EP1140993A1 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 10/10/2001 | EP1140941A1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 10/10/2001 | EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 10/10/2001 | EP1140920A1 Piperidines as ccr5 modulators |
| 10/10/2001 | EP1140913A1 Thiourea inhibitors of herpes viruses |
| 10/10/2001 | EP1140840A1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 10/10/2001 | EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands |
| 10/10/2001 | EP1140189A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
| 10/10/2001 | EP1140187A1 Combinations for cardiovascular indications |
| 10/10/2001 | EP1140159A1 Oral vaccine against diarrhea |
| 10/10/2001 | EP1140145A2 Novel exendin agonist formulations and methods of administration thereof |
| 10/10/2001 | EP1140124A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
| 10/10/2001 | EP1140115A2 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents |
| 10/10/2001 | EP1140102A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 10/10/2001 | EP1140085A1 Azabicycloalkanes as ccr5 modulators |
| 10/10/2001 | EP1140003A1 Skin care composition containing cis-9, trans-11 linoleic acid |
| 10/10/2001 | EP1139981A2 Compositions and methods of using the same |
| 10/10/2001 | CN1317045A Pharmaceutical uses of NAB1 and NAB2 |
| 10/10/2001 | CN1316995A Hydroxy 2-pipecolate hydroxamide acid derivatives as MMP inhititors |
| 10/10/2001 | CN1316993A 4,4-biarylpiperidime derivatives with opioid receptor activity |
| 10/09/2001 | US6300504 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates |
| 10/09/2001 | US6300475 Interferon PRO655 |
| 10/09/2001 | US6300295 Bleach, tartar remover with carbonates and bicarbonates |
| 10/09/2001 | CA2193224C Chinese herbs extract |
| 10/09/2001 | CA2164260C Targeting of dosages of medicines and therapeutic agents |
| 10/04/2001 | WO2001072288A2 Use of cdp-choline for the treatment of alcohol withdrawal syndrome |
| 10/04/2001 | WO2001072284A1 Granulated particles with masked taste |
| 10/04/2001 | WO2000015178A9 Computer implemented pharmacokinetics method and program |
| 10/04/2001 | US20010027202 Antitumor and -carcinogenic agents; solid cancers, e.g carcinomas of the lungs, pancreas, thyroid, bladder or color, myeloid disorders, e.g. leukemia or adenomas, e.g villous colon adenoma |
| 10/04/2001 | EP1137667A2 Analogues of glp-1 |
| 10/04/2001 | EP1137644A1 Benzofuran derivatives, their preparation and use |
| 10/04/2001 | EP1137642A1 Bis-sulfonamides |
| 10/04/2001 | EP1137439A2 Stabilization of macrolides |
| 10/04/2001 | EP1137392A1 Striped dentifrice |
| 10/04/2001 | EP0981350B1 Use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacalcidol |
| 10/04/2001 | EP0668876B1 Treatment of infertility and enhancement of fertilization capacity in mammalian males by thymosin peptide and its antibodies |
| 10/04/2001 | CA2403757A1 Granulated particles with masked taste |
| 10/03/2001 | CN1315961A Glycopeptide derivatives and pharmaceutical compositions containing same |
| 10/03/2001 | CN1315855A Immediate release tablet |